Compare MGNI & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGNI | LMAT |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | N/A | 2006 |
| Metric | MGNI | LMAT |
|---|---|---|
| Price | $16.48 | $84.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $26.80 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 2.8M | 197.8K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 219.02 | 27.40 |
| EPS | 0.38 | ★ 2.32 |
| Revenue | ★ $702,565,000.00 | $240,866,000.00 |
| Revenue This Year | $2.07 | $15.17 |
| Revenue Next Year | $10.93 | $9.07 |
| P/E Ratio | $43.69 | ★ $36.76 |
| Revenue Growth | 6.27 | ★ 13.07 |
| 52 Week Low | $8.22 | $71.42 |
| 52 Week High | $26.65 | $105.55 |
| Indicator | MGNI | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 49.35 |
| Support Level | $15.77 | $82.52 |
| Resistance Level | $17.21 | $87.09 |
| Average True Range (ATR) | 0.66 | 2.37 |
| MACD | 0.31 | 0.29 |
| Stochastic Oscillator | 75.88 | 57.74 |
Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.